Fulminating subacute sclerosing panencephalitis: Case report and literature review

Clinical Pediatrics

Volumn 36, Issue 3, 1997, Pages 149-154

  PeBenito, Rhandy ^a,b   Naqvi, Shehla H ^a   Arca, Marilyn M ^a   Schubert, Romaine ^a,b  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; INFECTION PREVENTION; MALE; PRESCHOOL CHILD; REVACCINATION; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION;

EID: 0030941492     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289703600306     Document Type: Review

References (31)

1. Dyken PR. Subacute sclerosing panencephalitis: current status. Neurol Clin. 1985;3:179-196.
2. Chen TT, Watanabe I, Zeman W, Mealey J. Subacute sclerosing panencephalitis propagation of measles virus from brain biopsy in tissue culture. Science. 1969:163:1193-1194.
3. Horta-Barbosa L, Fuccillo DA, London TW, et al. Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med. 1969;132:272-277.
4. Bergamini F, Defanti CA, Ferrante P, eds. Subacute Sclerosing Panencephalitis: A Reappraisal. New York: Elsevier; 1986.
5. Assaad F. Measles: summary of worldwide impact. Rev Infect Dis. 1983;5:452-459.
6. Ogle JW, Toltzis P, Parker WD, et al. Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis. 1989;159:748-750.
7. Fukuyama Y, Nihei K, Matsumoto S, et al. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis. A multi-institutional collaborative study. The Inosiplex SSPE Research Committee. Brain Dev. 1987;9:270-282.
8. Kuruki S, Tsutsui T, Yoshioka M, et al. The effect of intraventricular interferon on subacute sclerosing panencephalitis. Brain Dev. 1989;11:65-69.
9. Mehta PD, Kulczycki J, Patrick BA, et al. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis. J Neurol Sci. 1992;109:64-68.
10. Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984;19:376-379.
11. Aicardi J. Diseases of the Nervous System in Childhood. London: Mac Keith Press; 1992:651-653.
12. Baram TZ, Gonzalez-Gomez I, Xie ZD, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol. 1994;36:103-108.
13. Nelson DA, Weiner A, Yanoff M, de-Peralta J. Retinal lesions in subacute sclerosing panencephalitis. Arch Ophthalmol. 1970;84:613-621.
14. Font RL, Jenis EH, Tuck KD. Measles maculopathy associated with subacute sclerosing panencephalitis. Arch Pathol. 1973;96:168-174.
15. Case records of the Massachusetts General Hospital. N Engl J Med. 1974;290:273-279.
16. Gilden DH, Rorke LB, Tanaka R. Acute SSPE. Arch Neurol. 1975;32:644-646.
17. Nihei K, Kamoshita S, Mizutani H, et al. Atypical subacute sclerosing panencephalitis. Acta Neuropathol. 1977;38: 163-166.
18. Tamari H, Matsukura M, Matsuda I, et al. An acute variant of subacute sclerosing panencephalitis: an autopsy case report. Brain Dev. 1981;3:87-91.
19. Silva CA, Paula-Barbosa MM, Pereira S, Cruz C. Two cases of rapidly progressive subacute sclerosing panencephalitis. Arch Neurol. 1981;38:109-113.
20. Brudet-Wickel CL, Gogeweg M, de Wolff-Roudendaal D. Subacute sclerosing panencephalitis (SSPE). A case report. Dor Ophthalmol. 1982;52:241-250.
21. Dhib-Jalbut S, Liwnicz BH. Rapidly progressive subacute sclerosing panencephalitis: an ultrastructural and immunoperoxide study. Eur Neurol. 1984;23:211-220.
22. Wirguin I, Steiner I, Kidron D, et al. Fulminant subacute sclerosing panencephalitis in association with pregnancy. Arch Neurol. 1988;45:1324-1325.
23. Han-Sie T, Weber W, Freling G, et al. Rapidly fatal subacute sclerosing panencephalitis in a 19-year-old man. Eur Neurol. 1991;31:94-99.
24. Takayama S, Iwasaki Y, Yamanouchi HY, et al. Characteristic clinical features in a case of fulminant subacute sclerosing panencephalitis. Brain Dev. 1994;16:132-135.
25. Foley J, Williams D. Inclusion encephalitis and its relation to subacute sclerosing leucoencephalitis. Q J Med. 1953;22:157-194.
26. Poser CM, Radermecker J, BerchenAnvers B. Subacute sclerosing leukoencephalitis. J Pediatr. 1957;50:408-425.
27. Tibbles JAR, Donohue WL, Kofman O, Prichard JS. Subacute inclusion encephalitis: a clinical and pathological review. Can Med Assoc J. 1964;90:401-408.
28. Freeman JM. The clinical spectrum and early diagnosis of Dawson's encephalitis. J Pediatr. 1969;75:590-603.
29. Zagami AS, Lethlean AK. Chorioretinitis as a possible very early manifestation of subacute sclerosing panencephalitis. Aust NZ J Med. 1991;21: 350-352.
30. Yagi S, Miura Y, Kataoka N, et al. The origin of myoclonus and periodic synchronous discharges in subacute sclerosing panencephalitis. Acta Paediatr Jpn. 1992;34:310-315.
31. Bohlega S, Al-Kawi MZ. Subacute sclerosing panencephalitis. Imaging and clinical correlation. J Neuroimaging. 1994;4:71-76.